{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:26:43Z","timestamp":1768973203999,"version":"3.49.0"},"reference-count":166,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["51771-10107"],"award-info":[{"award-number":["51771-10107"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>The over-expression of the Bcl-2 protein is a common feature of many solid cancers and hematological malignancies, and it is typically associated with poor prognosis and resistance to chemotherapy. Bcl-2-specific inhibitors, such as venetoclax, have recently been approved for the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma, and they are showing promise in clinical trials as a targeted therapy for patients with relapsed or refractory acute myeloid leukemia (AML). However, successful treatment of AML with Bcl-2-specific inhibitors is often followed by the rapid development of drug resistance. An emerging paradigm for overcoming drug resistance in cancer treatment is through the targeting of mitochondrial energetics and metabolism. In AML in particular, it was recently observed that inhibition of mitochondrial translation via administration of the antibiotic tedizolid significantly affects mitochondrial bioenergetics, activating the integrated stress response (ISR) and subsequently sensitizing drug-resistant AML cells to venetoclax. Here we develop an integrative systems biology approach to acquire a deeper understanding of the molecular mechanisms behind this process, and in particular, of the specific role of the ISR in the commitment of cells to apoptosis. Our multi-scale mathematical model couples the ISR to the intrinsic apoptosis pathway in venetoclax-resistant AML cells, includes the metabolic effects of treatment, and integrates RNA, protein level, and cellular viability data. Using the mathematical model, we identify the dominant mechanisms by which ISR activation helps to overcome venetoclax resistance, and we study the temporal sequencing of combination treatment to determine the most efficient and robust combination treatment protocol.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1010439","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T17:24:46Z","timestamp":1663089886000},"page":"e1010439","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8071-6599","authenticated-orcid":true,"given":"Michelle","family":"Przedborski","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-3167","authenticated-orcid":true,"given":"David","family":"Sharon","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7693-991X","authenticated-orcid":true,"given":"Severine","family":"Cathelin","sequence":"additional","affiliation":[]},{"given":"Steven","family":"Chan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0667-7269","authenticated-orcid":true,"given":"Mohammad","family":"Kohandel","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"key":"pcbi.1010439.ref001","article-title":"Blood Cancer in Canada Facts & Stats 2016","author":"Hodgson CS and Associaters","year":"2016","journal-title":"Leukemia and Lymphoma Society of Canada"},{"key":"pcbi.1010439.ref002","volume-title":"Canadian Cancer Statistics 2019","author":"Canadian Cancer Statistics Advisory Committee","year":"2019"},{"issue":"2","key":"pcbi.1010439.ref003","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm.3788","article-title":"Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia","volume":"21","author":"SM Chan","year":"2015","journal-title":"Nature medicine"},{"issue":"5","key":"pcbi.1010439.ref004","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.18632\/oncotarget.6405","article-title":"Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species","volume":"7","author":"HD Um","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"pcbi.1010439.ref005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-018-0608-2","article-title":"BCL-2 as therapeutic target for hematological malignancies","volume":"11","author":"GF Perini","year":"2018","journal-title":"Journal of hematology & oncology"},{"issue":"11","key":"pcbi.1010439.ref006","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1182\/blood.V81.11.3091.3091","article-title":"High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy","volume":"81","author":"L Campos","year":"1993","journal-title":"Blood"},{"issue":"2","key":"pcbi.1010439.ref007","first-page":"98","article-title":"Bcl-2 oncoprotein expression in acute myeloid leukemia","volume":"80","author":"L Bensi","year":"1995","journal-title":"Haematologica"},{"issue":"3","key":"pcbi.1010439.ref008","first-page":"141","article-title":"High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy","volume":"49","author":"E Tothova","year":"2002","journal-title":"Neoplasma"},{"issue":"10","key":"pcbi.1010439.ref009","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/2159-8290.CD-16-0921","article-title":"BCL2 inhibition by venetoclax: targeting the Achilles\u2019 heel of the acute myeloid leukemia stem cell?","volume":"6","author":"VA Pullarkat","year":"2016","journal-title":"Cancer discovery"},{"issue":"9","key":"pcbi.1010439.ref010","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1080\/10428194.2017.1283032","article-title":"Pathways and mechanisms of venetoclax resistance","volume":"58","author":"P Bose","year":"2017","journal-title":"Leukemia & lymphoma"},{"key":"pcbi.1010439.ref011","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/OTT.S191621","article-title":"Mechanisms of drug resistance in acute myeloid leukemia","volume":"12","author":"J Zhang","year":"2019","journal-title":"OncoTargets and therapy"},{"issue":"12","key":"pcbi.1010439.ref012","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/2159-8290.CD-18-0387","article-title":"AMG 176, a selective MCL1 inhibitor, is effective in hematologic cancer models alone and in combination with established therapies","volume":"8","author":"S Caenepeel","year":"2018","journal-title":"Cancer discovery"},{"issue":"12","key":"pcbi.1010439.ref013","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","article-title":"A novel MCL1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous leukemia","volume":"8","author":"HE Ramsey","year":"2018","journal-title":"Cancer discovery"},{"issue":"4","key":"pcbi.1010439.ref014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41375-018-0261-3","article-title":"Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia","volume":"33","author":"DM Moujalled","year":"2019","journal-title":"Leukemia"},{"issue":"6","key":"pcbi.1010439.ref015","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ccell.2017.11.003","article-title":"Synthetic lethality of combined Bcl-2 inhibition and p53 activation in AML: mechanisms and superior antileukemic efficacy","volume":"32","author":"R Pan","year":"2017","journal-title":"Cancer Cell"},{"issue":"4","key":"pcbi.1010439.ref016","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/leu.2011.287","article-title":"MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1\/BIM complex","volume":"26","author":"M Konopleva","year":"2012","journal-title":"Leukemia"},{"issue":"5712","key":"pcbi.1010439.ref017","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.1106114","article-title":"Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells","volume":"307","author":"JT Opferman","year":"2005","journal-title":"Science"},{"issue":"9","key":"pcbi.1010439.ref018","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1182\/blood-2009-12-258095","article-title":"The human stem cell hierarchy is defined by a functional dependence on Mcl-1 for self-renewal capacity","volume":"116","author":"CJ Campbell","year":"2010","journal-title":"Blood"},{"issue":"12","key":"pcbi.1010439.ref019","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1101\/gad.215871.113","article-title":"Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure","volume":"27","author":"RL Thomas","year":"2013","journal-title":"Genes & development"},{"issue":"2","key":"pcbi.1010439.ref020","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.22664","article-title":"Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes","volume":"49","author":"B Vick","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"pcbi.1010439.ref021","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.cdd.4402081","article-title":"Bcl-2 family proteins are essential for platelet survival","volume":"14","author":"H Zhang","year":"2007","journal-title":"Cell death and differentiation"},{"issue":"6","key":"pcbi.1010439.ref022","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","article-title":"Programmed anuclear cell death delimits platelet life span","volume":"128","author":"KD Mason","year":"2007","journal-title":"Cell"},{"issue":"26","key":"pcbi.1010439.ref023","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1182\/blood-2011-03-344812","article-title":"BCL2\/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation","volume":"117","author":"M Vogler","year":"2011","journal-title":"Blood"},{"issue":"5","key":"pcbi.1010439.ref024","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cmet.2017.10.013","article-title":"Resistance is futile: targeting mitochondrial energetics and metabolism to overcome drug resistance in cancer treatment","volume":"26","author":"C Bosc","year":"2017","journal-title":"Cell metabolism"},{"issue":"5","key":"pcbi.1010439.ref025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"M \u0160krti\u0107","year":"2011","journal-title":"Cancer cell"},{"issue":"516","key":"pcbi.1010439.ref026","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2863","article-title":"Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response","volume":"11","author":"D Sharon","year":"2019","journal-title":"Science translational medicine"},{"key":"pcbi.1010439.ref027","first-page":"1","article-title":"A review of mathematical models for leukemia and lymphoma","volume":"16","author":"G Clapp","year":"2015","journal-title":"Drug Discovery Today: Disease Models"},{"issue":"8","key":"pcbi.1010439.ref028","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3324\/haematol.13209","article-title":"A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)","volume":"93","author":"A Liso","year":"2008","journal-title":"haematologica"},{"issue":"1","key":"pcbi.1010439.ref029","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/17486700902973751","article-title":"A hypothetical-mathematical model of acute myeloid leukaemia pathogenesis","volume":"11","author":"A Cucuianu","year":"2010","journal-title":"Computational and Mathematical Methods in Medicine"},{"issue":"14","key":"pcbi.1010439.ref030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3182\/20120622-3-US-4021.00047","article-title":"A new model of cell dynamics in Acute Myeloid Leukemia involving distributed delays","volume":"45","author":"JL Avila","year":"2012","journal-title":"IFAC Proceedings Volumes"},{"key":"pcbi.1010439.ref031","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-3-319-01695-5_23","volume-title":"Delay Systems","author":"JL Avila","year":"2014"},{"key":"pcbi.1010439.ref032","doi-asserted-by":"crossref","unstructured":"Avila J, Bonnet C, Fridman E, Mazenc F, Clairambault J. Stability analysis of PDEs modelling cell dynamics in acute myeloid leukemia. In: 53rd IEEE Conference on Decision and Control. IEEE; 2014. p. 3059\u20133064.","DOI":"10.1109\/CDC.2014.7039860"},{"issue":"3","key":"pcbi.1010439.ref033","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.3182\/20140824-6-ZA-1003.02574","article-title":"A coupled model for healthy and cancerous cells dynamics in Acute Myeloid Leukemia","volume":"47","author":"J Avila","year":"2014","journal-title":"IFAC Proceedings Volumes"},{"issue":"1","key":"pcbi.1010439.ref034","doi-asserted-by":"crossref","first-page":"15103","DOI":"10.1016\/j.ifacol.2017.08.2240","article-title":"Global stability analysis of healthy situation for a coupled model of healthy and cancerous cells dynamics in acute myeloid leukemia","volume":"50","author":"A Zenati","year":"2017","journal-title":"IFAC-PapersOnLine"},{"issue":"Suppl 1","key":"pcbi.1010439.ref035","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.30707\/LiB5.2Cho","article-title":"Modelling acute myeloid leukaemia in a continuum of differentiation states","volume":"5","author":"H Cho","year":"2018","journal-title":"Letters in biomathematics"},{"issue":"1","key":"pcbi.1010439.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-21115-4","article-title":"Mathematical modeling of the impact of cytokine response of acute myeloid leukemia cells on patient prognosis","volume":"8","author":"T Stiehl","year":"2018","journal-title":"Scientific reports"},{"issue":"10","key":"pcbi.1010439.ref037","doi-asserted-by":"crossref","first-page":"e0204393","DOI":"10.1371\/journal.pone.0204393","article-title":"A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia","volume":"13","author":"F J\u00e4kel","year":"2018","journal-title":"Plos one"},{"issue":"49","key":"pcbi.1010439.ref038","doi-asserted-by":"crossref","first-page":"24593","DOI":"10.1073\/pnas.1904091116","article-title":"Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemia","volume":"116","author":"A Agarwal","year":"2019","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"pcbi.1010439.ref039","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/math8030376","article-title":"A mathematical model of the transition from normal hematopoiesis to the chronic and accelerated-acute stages in myeloid leukemia","volume":"8","author":"LG Parajdi","year":"2020","journal-title":"Mathematics"},{"key":"pcbi.1010439.ref040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.compchemeng.2013.02.003","article-title":"Design of optimal patient-specific chemotherapy protocols for the treatment of acute myeloid leukemia (AML)","volume":"57","author":"E Pefani","year":"2013","journal-title":"Computers & chemical engineering"},{"issue":"7","key":"pcbi.1010439.ref041","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1109\/TBME.2014.2313226","article-title":"Chemotherapy drug scheduling for the induction treatment of patients with acute myeloid leukemia","volume":"61","author":"E Pefani","year":"2014","journal-title":"IEEE Transactions on Biomedical Engineering"},{"issue":"10","key":"pcbi.1010439.ref042","doi-asserted-by":"crossref","first-page":"e1005129","DOI":"10.1371\/journal.pcbi.1005129","article-title":"Optimized treatment schedules for chronic myeloid leukemia","volume":"12","author":"Q He","year":"2016","journal-title":"PLoS computational biology"},{"key":"pcbi.1010439.ref043","doi-asserted-by":"crossref","unstructured":"Abdelhafid Z, Chakir M, Mohamed T. Optimal control of a coupled model for healthy and cancerous cells dynamics in acute myeloid leukemia-a therapy approach. In: 2017 6th International Conference on Systems and Control (ICSC). IEEE; 2017. p. 543\u2013548.","DOI":"10.1109\/ICoSC.2017.7958684"},{"issue":"7","key":"pcbi.1010439.ref044","doi-asserted-by":"crossref","first-page":"e0204540","DOI":"10.1371\/journal.pone.0204540","article-title":"Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia","volume":"14","author":"F Jost","year":"2019","journal-title":"PloS one"},{"issue":"1","key":"pcbi.1010439.ref045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12918-019-0684-0","article-title":"In-silico comparison of two induction regimens (7+ 3 vs 7+ 3 plus additional bone marrow evaluation) in acute myeloid leukemia treatment","volume":"13","author":"JC Banck","year":"2019","journal-title":"BMC systems biology"},{"key":"pcbi.1010439.ref046","first-page":"012003","volume-title":"Journal of Physics: Conference Series","author":"YA Adi","year":"2020"},{"key":"pcbi.1010439.ref047","first-page":"170","article-title":"Fitting Personalized Mechanistic Mathematical Models of Acute Myeloid Leukaemia to Clinical Patient Data","author":"D G\u00f6rlich","year":"2021","journal-title":"BIOINFORMATICS"},{"issue":"9","key":"pcbi.1010439.ref048","first-page":"2577","article-title":"Towards individualized follow-up in adult acute myeloid leukemia in remission","volume":"117","author":"P Hokland","year":"2011","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"6","key":"pcbi.1010439.ref049","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1158\/0008-5472.CAN-14-2508","article-title":"Cell division patterns in acute myeloid leukemia stem-like cells determine clinical course: a model to predict patient survival","volume":"75","author":"T Stiehl","year":"2015","journal-title":"Cancer research"},{"issue":"9","key":"pcbi.1010439.ref050","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3324\/haematol.2016.163584","article-title":"Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia","volume":"102","author":"W Wang","year":"2017","journal-title":"Haematologica"},{"issue":"12","key":"pcbi.1010439.ref051","doi-asserted-by":"crossref","first-page":"123150","DOI":"10.1063\/5.0023830","article-title":"Using mathematical models to improve risk-scoring in acute myeloid leukemia","volume":"30","author":"T Stiehl","year":"2020","journal-title":"Chaos: An Interdisciplinary Journal of Nonlinear Science"},{"issue":"18","key":"pcbi.1010439.ref052","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1158\/0008-5472.CAN-20-0283","article-title":"Mathematical modeling provides evidence for niche competition in human AML and serves as a tool to improve risk stratification","volume":"80","author":"T Stiehl","year":"2020","journal-title":"Cancer Research"},{"issue":"170","key":"pcbi.1010439.ref053","doi-asserted-by":"crossref","first-page":"20200091","DOI":"10.1098\/rsif.2020.0091","article-title":"Differential response to cytotoxic therapy explains treatment dynamics of acute myeloid leukaemia patients: insights from a mathematical modelling approach","volume":"17","author":"H Hoffmann","year":"2020","journal-title":"Journal of the Royal Society Interface"},{"key":"pcbi.1010439.ref054","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fgene.2015.00290","article-title":"Normal vs. Malignant hematopoiesis: the complexity of acute leukemia through systems biology","volume":"6","author":"J Enciso","year":"2015","journal-title":"Frontiers in genetics"},{"issue":"3","key":"pcbi.1010439.ref055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/jpm11030193","article-title":"Data-Driven Math Model of FLT3-ITD Acute Myeloid Leukemia Reveals Potential Therapeutic Targets","volume":"11","author":"DJ Wooten","year":"2021","journal-title":"Journal of personalized medicine"},{"key":"pcbi.1010439.ref056","first-page":"020062","volume-title":"AIP Conference Proceedings","author":"Y Adi","year":"2016"},{"key":"pcbi.1010439.ref057","article-title":"A dynamic model of pi3k\/akt pathways in acute myeloid leukemia","volume":"2018","author":"YA Adi","year":"2018","journal-title":"Journal of Applied Mathematics"},{"issue":"2","key":"pcbi.1010439.ref058","doi-asserted-by":"crossref","first-page":"183","DOI":"10.17654\/DE021020183","article-title":"BACKWARD BIFURCATION IN A MATHEMATICAL MODEL OF PI3K\/AKT PATHWAYS IN ACUTE MYELOID LEUKEMIA","volume":"21","author":"Y Adi","year":"2019","journal-title":"Advances in Differential Equations and Control Processes"},{"issue":"5","key":"pcbi.1010439.ref059","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1529\/biophysj.105.068122","article-title":"Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores","volume":"90","author":"E Bagci","year":"2006","journal-title":"Biophysical journal"},{"issue":"9","key":"pcbi.1010439.ref060","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pcbi.0020120","article-title":"Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability","volume":"2","author":"S Legewie","year":"2006","journal-title":"PLoS computational biology"},{"issue":"26","key":"pcbi.1010439.ref061","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1016\/j.febslet.2007.09.063","article-title":"Robustness analysis identifies the plausible model of the Bcl-2 apoptotic switch","volume":"581","author":"C Chen","year":"2007","journal-title":"FEBS letters"},{"issue":"1","key":"pcbi.1010439.ref062","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molcel.2008.02.012","article-title":"Quantitative analysis of pathways controlling extrinsic apoptosis in single cells","volume":"30","author":"JG Albeck","year":"2008","journal-title":"Molecular cell"},{"issue":"1","key":"pcbi.1010439.ref063","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-4682-5-26","article-title":"Construction and analysis of a modular model of caspase activation in apoptosis","volume":"5","author":"HA Harrington","year":"2008","journal-title":"Theoretical Biology and Medical Modelling"},{"issue":"1","key":"pcbi.1010439.ref064","doi-asserted-by":"crossref","first-page":"e1469","DOI":"10.1371\/journal.pone.0001469","article-title":"Two independent positive feedbacks and bistability in the Bcl-2 apoptotic switch","volume":"3","author":"J Cui","year":"2008","journal-title":"PLoS One"},{"issue":"4","key":"pcbi.1010439.ref065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/cdd.2008.187","article-title":"Dynamics of outer mitochondrial membrane permeabilization during apoptosis","volume":"16","author":"M Rehm","year":"2009","journal-title":"Cell death and differentiation"},{"issue":"5","key":"pcbi.1010439.ref066","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.febslet.2010.01.034","article-title":"Evaluating bistability of Bax activation switch","volume":"584","author":"T Sun","year":"2010","journal-title":"FEBS letters"},{"issue":"23","key":"pcbi.1010439.ref067","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1016\/j.physa.2012.07.006","article-title":"Computational study of the mechanism of Bcl-2 apoptotic switch","volume":"391","author":"T Tok\u00e1r","year":"2012","journal-title":"Physica A: Statistical Mechanics and its Applications"},{"issue":"10","key":"pcbi.1010439.ref068","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10495-010-0515-7","article-title":"Bcl-2 inhibits apoptosis by increasing the time-to-death and intrinsic cell-to-cell variations in the mitochondrial pathway of cell death","volume":"15","author":"J Skommer","year":"2010","journal-title":"Apoptosis"},{"issue":"6","key":"pcbi.1010439.ref069","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.cell.2011.03.002","article-title":"Measuring and modeling apoptosis in single cells","volume":"144","author":"SL Spencer","year":"2011","journal-title":"Cell"},{"issue":"4","key":"pcbi.1010439.ref070","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbamcr.2010.10.004","article-title":"Mathematical modelling of the mitochondrial apoptosis pathway","volume":"1813","author":"HJ Huber","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"issue":"12","key":"pcbi.1010439.ref071","doi-asserted-by":"crossref","first-page":"e81861","DOI":"10.1371\/journal.pone.0081861","article-title":"The mathematical model of the Bcl-2 family mediated MOMP regulation can perform a non-trivial pattern recognition","volume":"8","author":"T Tokar","year":"2013","journal-title":"PloS one"},{"issue":"2","key":"pcbi.1010439.ref072","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1158\/0008-5472.CAN-12-2269","article-title":"Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy","volume":"73","author":"AU Lindner","year":"2013","journal-title":"Cancer research"},{"issue":"1","key":"pcbi.1010439.ref073","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1478-811X-11-44","article-title":"Mathematical modeling of apoptosis","volume":"11","author":"K Schleich","year":"2013","journal-title":"Cell Communication and Signaling"},{"issue":"5","key":"pcbi.1010439.ref074","doi-asserted-by":"crossref","first-page":"e1258","DOI":"10.1038\/cddis.2014.36","article-title":"From computational modelling of the intrinsic apoptosis pathway to a systems-based analysis of chemotherapy resistance: achievements, perspectives and challenges in systems medicine","volume":"5","author":"M W\u00fcrstle","year":"2014","journal-title":"Cell death & disease"},{"issue":"2","key":"pcbi.1010439.ref075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41419-017-0039-y","article-title":"Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells","volume":"9","author":"F Lucantoni","year":"2018","journal-title":"Cell death & disease"},{"key":"pcbi.1010439.ref076","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1874340400802010071","article-title":"The stress-response network in animals: proposals to develop a predictive mathematical model","volume":"2","author":"D de Pomerai","year":"2008","journal-title":"Open Toxicol J"},{"issue":"1","key":"pcbi.1010439.ref077","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1752-0509-7-16","article-title":"A mathematical model of the unfolded protein stress response reveals the decision mechanism for recovery, adaptation and apoptosis","volume":"7","author":"K Erguler","year":"2013","journal-title":"BMC systems biology"},{"issue":"1","key":"pcbi.1010439.ref078","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/ijms19010308","article-title":"Post-transcriptional regulation of anti-apoptotic BCL2 family members","volume":"19","author":"J Cui","year":"2018","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"pcbi.1010439.ref079","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/156652408783769599","article-title":"Regulation of Bcl-2 family proteins by posttranslational modifications","volume":"8","author":"A Letai","year":"2008","journal-title":"Current molecular medicine"},{"key":"pcbi.1010439.ref080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcell.2018.00013","article-title":"Subcellular localization and dynamics of the Bcl-2 family of proteins","volume":"6","author":"N Popgeorgiev","year":"2018","journal-title":"Frontiers in cell and developmental biology"},{"issue":"1","key":"pcbi.1010439.ref081","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/onc.2009.39","article-title":"BH3-only proteins in apoptosis and beyond: an overview","volume":"27","author":"E Lomonosova","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"pcbi.1010439.ref082","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbamcr.2010.11.024","article-title":"BH3-only proteins: Orchestrators of apoptosis","volume":"1813","author":"A Shamas-Din","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"issue":"12","key":"pcbi.1010439.ref083","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ncb1499","article-title":"Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies","volume":"8","author":"H Kim","year":"2006","journal-title":"Nature cell biology"},{"issue":"4","key":"pcbi.1010439.ref084","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.molcel.2011.10.001","article-title":"A unified model of mammalian BCL-2 protein family interactions at the mitochondria","volume":"44","author":"F Llambi","year":"2011","journal-title":"Molecular cell"},{"issue":"1","key":"pcbi.1010439.ref085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/cdd.2017.161","article-title":"The BCL-2 arbiters of apoptosis and their growing role as cancer targets","volume":"25","author":"JM Adams","year":"2018","journal-title":"Cell death and differentiation"},{"issue":"1","key":"pcbi.1010439.ref086","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"J Kale","year":"2018","journal-title":"Cell death and differentiation"},{"issue":"4","key":"pcbi.1010439.ref087","doi-asserted-by":"crossref","first-page":"a008714","DOI":"10.1101\/cshperspect.a008714","article-title":"Mechanisms of action of Bcl-2 family proteins","volume":"5","author":"A Shamas-Din","year":"2013","journal-title":"Cold Spring Harbor perspectives in biology"},{"issue":"3","key":"pcbi.1010439.ref088","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","article-title":"Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function","volume":"17","author":"L Chen","year":"2005","journal-title":"Molecular cell"},{"issue":"17","key":"pcbi.1010439.ref089","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/cmdc.201800321","article-title":"Experimental Characterization of the Binding Affinities between Proapoptotic BH3 Peptides and Antiapoptotic Bcl-2 Proteins","volume":"13","author":"W Kong","year":"2018","journal-title":"ChemMedChem"},{"issue":"12","key":"pcbi.1010439.ref090","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.cdd.4400783","article-title":"Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c","volume":"7","author":"S Korsmeyer","year":"2000","journal-title":"Cell death and differentiation"},{"issue":"22","key":"pcbi.1010439.ref091","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1242\/jcs.00829","article-title":"Bcl-2 on the endoplasmic reticulum: protecting the mitochondria from a distance","volume":"116","author":"MJ Thomenius","year":"2003","journal-title":"Journal of Cell Science"},{"issue":"9","key":"pcbi.1010439.ref092","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.cdd.4401950","article-title":"Mechanisms of cytochrome c release from mitochondria","volume":"13","author":"C Garrido","year":"2006","journal-title":"Cell death and differentiation"},{"issue":"2","key":"pcbi.1010439.ref093","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10495-006-0574-y","article-title":"Reticulon 3 mediates Bcl-2 accumulation in mitochondria in response to endoplasmic reticulum stress","volume":"12","author":"Q Wan","year":"2007","journal-title":"Apoptosis"},{"issue":"9","key":"pcbi.1010439.ref094","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrm2952","article-title":"Mitochondria and cell death: outer membrane permeabilization and beyond","volume":"11","author":"SW Tait","year":"2010","journal-title":"Nature reviews Molecular cell biology"},{"issue":"4","key":"pcbi.1010439.ref095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbamcr.2010.11.012","article-title":"Integrating stress signals at the endoplasmic reticulum: the BCL-2 protein family rheostat","volume":"1813","author":"D Rodriguez","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"issue":"4","key":"pcbi.1010439.ref096","doi-asserted-by":"crossref","first-page":"a008656","DOI":"10.1101\/cshperspect.a008656","article-title":"Caspase functions in cell death and disease","volume":"5","author":"DR McIlwain","year":"2013","journal-title":"Cold Spring Harbor perspectives in biology"},{"issue":"6-8","key":"pcbi.1010439.ref097","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/09687688.2017.1400600","article-title":"Regulation of stressed-induced cell death by the Bcl-2 family of apoptotic proteins","volume":"33","author":"R Roufayel","year":"2016","journal-title":"Molecular membrane biology"},{"issue":"10","key":"pcbi.1010439.ref098","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.bbamcr.2014.04.017","article-title":"A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum","volume":"1843","author":"H Akl","year":"2014","journal-title":"Biochimica et biophysica acta (BBA)-molecular cell research"},{"issue":"1","key":"pcbi.1010439.ref099","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10863-013-9527-7","article-title":"Bcl-2 family in inter-organelle modulation of calcium signaling; roles in bioenergetics and cell survival","volume":"46","author":"A Lewis","year":"2014","journal-title":"Journal of bioenergetics and biomembranes"},{"issue":"1","key":"pcbi.1010439.ref100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"D Hanahan","year":"2000","journal-title":"cell"},{"issue":"5","key":"pcbi.1010439.ref101","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"cell"},{"issue":"16","key":"pcbi.1010439.ref102","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1158\/1078-0432.CCR-17-3004","article-title":"Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas","volume":"24","author":"LV Pham","year":"2018","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"pcbi.1010439.ref103","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/cdd.2009.132","article-title":"Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2","volume":"17","author":"Z Chen","year":"2010","journal-title":"Cell death and differentiation"},{"issue":"9","key":"pcbi.1010439.ref104","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/sj.cdd.4402165","article-title":"Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells","volume":"14","author":"ZX Chen","year":"2007","journal-title":"Cell death and differentiation"},{"issue":"3","key":"pcbi.1010439.ref105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/BJ20101996","article-title":"Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2","volume":"435","author":"S Krishna","year":"2011","journal-title":"Biochemical Journal"},{"issue":"11","key":"pcbi.1010439.ref106","first-page":"1346","article-title":"Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition","volume":"126","author":"N Jacque","year":"2015","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"30","key":"pcbi.1010439.ref107","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1038\/onc.2015.464","article-title":"Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax","volume":"35","author":"R Bajpai","year":"2016","journal-title":"Oncogene"},{"issue":"6098","key":"pcbi.1010439.ref108","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"RJ Youle","year":"2012","journal-title":"Science"},{"issue":"12","key":"pcbi.1010439.ref109","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/sj.emboj.7600675","article-title":"Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis","volume":"24","author":"MG Annis","year":"2005","journal-title":"The EMBO journal"},{"issue":"1","key":"pcbi.1010439.ref110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"RJ Youle","year":"2008","journal-title":"Nature reviews Molecular cell biology"},{"issue":"5","key":"pcbi.1010439.ref111","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.molcel.2012.12.022","article-title":"Bax exists in a dynamic equilibrium between the cytosol and mitochondria to control apoptotic priming","volume":"49","author":"B Schellenberg","year":"2013","journal-title":"Molecular cell"},{"issue":"18","key":"pcbi.1010439.ref112","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.18632\/oncotarget.2320","article-title":"Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory complex-I activity via Bcl-2 family proteins","volume":"5","author":"EM Kim","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"pcbi.1010439.ref113","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cellsig.2012.01.019","article-title":"Bcl-w promotes cell invasion by blocking the invasion-suppressing action of Bax","volume":"24","author":"EM Kim","year":"2012","journal-title":"Cellular signalling"},{"issue":"18","key":"pcbi.1010439.ref114","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.18632\/oncotarget.2320","article-title":"Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory complex-I activity via Bcl-2 family proteins","volume":"5","author":"EM Kim","year":"2014","journal-title":"Oncotarget"},{"issue":"9","key":"pcbi.1010439.ref115","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4161\/cc.3.9.1145","article-title":"The life cycle of C-myc: from synthesis to degradation","volume":"3","author":"RC Sears","year":"2004","journal-title":"Cell cycle"},{"key":"pcbi.1010439.ref116","doi-asserted-by":"crossref","first-page":"105919","DOI":"10.1016\/j.ejps.2021.105919","article-title":"A mean-field approach for modeling the propagation of perturbations in biochemical reaction networks","volume":"165","author":"M Przedborski","year":"2021","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"1","key":"pcbi.1010439.ref117","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"CV Dang","year":"2012","journal-title":"Cell"},{"issue":"10","key":"pcbi.1010439.ref118","doi-asserted-by":"crossref","first-page":"a014415","DOI":"10.1101\/cshperspect.a014415","article-title":"Neuroblastoma and MYCN","volume":"3","author":"M Huang","year":"2013","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"11","key":"pcbi.1010439.ref119","doi-asserted-by":"crossref","first-page":"a014308","DOI":"10.1101\/cshperspect.a014308","article-title":"Role of MYC in Medulloblastoma","volume":"3","author":"MF Roussel","year":"2013","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"6","key":"pcbi.1010439.ref120","doi-asserted-by":"crossref","first-page":"a014241","DOI":"10.1101\/cshperspect.a014241","article-title":"MYC activation is a hallmark of cancer initiation and maintenance","volume":"4","author":"M Gabay","year":"2014","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"2","key":"pcbi.1010439.ref121","doi-asserted-by":"crossref","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"R Schmitz","year":"2014","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"6","key":"pcbi.1010439.ref122","first-page":"552","volume":"1807","author":"C Jose","year":"2011","journal-title":"Choosing between glycolysis and oxidative phosphorylation: a tumor\u2019s dilemma? Biochimica et Biophysica Acta (BBA)-Bioenergetics"},{"issue":"6","key":"pcbi.1010439.ref123","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2015.09.025","article-title":"Oncogenic Myc induces expression of glutamine synthetase through promoter demethylation","volume":"22","author":"AJ Bott","year":"2015","journal-title":"Cell metabolism"},{"key":"pcbi.1010439.ref124","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2018.00129","article-title":"The role for Myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues","volume":"9","author":"ES Goetzman","year":"2018","journal-title":"Frontiers in endocrinology"},{"key":"pcbi.1010439.ref125","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.2147\/OTT.S180520","article-title":"Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer","volume":"11","author":"Y Wu","year":"2018","journal-title":"OncoTargets and therapy"},{"issue":"1","key":"pcbi.1010439.ref126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat","volume":"5","author":"Y Dong","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"pcbi.1010439.ref127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.19.1.1","article-title":"c-Myc target genes involved in cell growth, apoptosis, and metabolism","volume":"19","author":"CV Dang","year":"1999","journal-title":"Molecular and cellular biology"},{"issue":"8","key":"pcbi.1010439.ref128","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.4161\/cc.20008","article-title":"MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors","volume":"11","author":"WL Labisso","year":"2012","journal-title":"Cell cycle"},{"issue":"11","key":"pcbi.1010439.ref129","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1128\/MCB.25.11.4488-4500.2005","article-title":"Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria","volume":"25","author":"T Tong","year":"2005","journal-title":"Molecular and cellular biology"},{"issue":"24","key":"pcbi.1010439.ref130","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1128\/MCB.06297-11","article-title":"Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYC","volume":"31","author":"XY Zhang","year":"2011","journal-title":"Molecular and cellular biology"},{"issue":"7","key":"pcbi.1010439.ref131","doi-asserted-by":"crossref","first-page":"a014407","DOI":"10.1101\/cshperspect.a014407","article-title":"MYC and the control of apoptosis","volume":"4","author":"SB McMahon","year":"2014","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"9","key":"pcbi.1010439.ref132","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.bpj.2011.09.052","article-title":"Qualitative network modeling of the Myc-p53 control system of cell proliferation and differentiation","volume":"101","author":"BD Aguda","year":"2011","journal-title":"Biophysical journal"},{"issue":"6","key":"pcbi.1010439.ref133","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4161\/cc.2.6.550","article-title":"A structural analysis of the qualitative networks regulating the cell cycle and apoptosis","volume":"2","author":"BD Aguda","year":"2003","journal-title":"Cell Cycle"},{"issue":"6","key":"pcbi.1010439.ref134","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccr.2008.10.018","article-title":"Distinct thresholds govern Myc\u2019s biological output in vivo","volume":"14","author":"DJ Murphy","year":"2008","journal-title":"Cancer cell"},{"issue":"50","key":"pcbi.1010439.ref135","doi-asserted-by":"crossref","first-page":"19678","DOI":"10.1073\/pnas.0811166106","article-title":"MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc","volume":"105","author":"BD Aguda","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"50","key":"pcbi.1010439.ref136","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2008.312","article-title":"Apoptotic signaling by c-MYC","volume":"27","author":"B Hoffman","year":"2008","journal-title":"Oncogene"},{"issue":"15","key":"pcbi.1010439.ref137","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1128\/MCB.21.15.5063-5070.2001","article-title":"Apoptosis triggered by Myc-induced suppression of Bcl-XL or Bcl-2 is bypassed during lymphomagenesis","volume":"21","author":"CM Eischen","year":"2001","journal-title":"Molecular and cellular biology"},{"issue":"48","key":"pcbi.1010439.ref138","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1038\/sj.onc.1204892","article-title":"Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1","volume":"20","author":"CM Eischen","year":"2001","journal-title":"Oncogene"},{"issue":"8","key":"pcbi.1010439.ref139","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/cdd.2016.9","article-title":"Histone deacetylase inhibition reveals a tumor-suppressive function of MYC-regulated miRNA in breast and lung carcinoma","volume":"23","author":"C Adams","year":"2016","journal-title":"Cell Death & Differentiation"},{"issue":"3","key":"pcbi.1010439.ref140","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/0008-5472.CAN-15-1751","article-title":"Myc induces miRNA-mediated apoptosis in response to HDAC inhibition in hematologic malignancies","volume":"76","author":"CM Adams","year":"2016","journal-title":"Cancer research"},{"issue":"2","key":"pcbi.1010439.ref141","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1172\/JCI89486","article-title":"BCL-W has a fundamental role in B cell survival and lymphomagenesis","volume":"127","author":"CM Adams","year":"2017","journal-title":"The Journal of clinical investigation"},{"issue":"10","key":"pcbi.1010439.ref142","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1242\/jcs.00408","article-title":"The unfolded protein response","volume":"116","author":"CY Liu","year":"2003","journal-title":"Journal of Cell Science"},{"issue":"3","key":"pcbi.1010439.ref143","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ncb0311-184","article-title":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"I Tabas","year":"2011","journal-title":"Nature cell biology"},{"issue":"22","key":"pcbi.1010439.ref144","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1091\/mbc.e11-06-0510","article-title":"The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress","volume":"22","author":"BF Teske","year":"2011","journal-title":"Molecular biology of the cell"},{"issue":"10","key":"pcbi.1010439.ref145","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"K Pakos-Zebrucka","year":"2016","journal-title":"EMBO reports"},{"key":"pcbi.1010439.ref146","article-title":"The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection","volume":"9","author":"H Hu","year":"2018","journal-title":"Frontiers in immunology"},{"issue":"3","key":"pcbi.1010439.ref147","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/cr.2018.16","article-title":"UPR mt regulation and output: a stress response mediated by mitochondrial-nuclear communication","volume":"28","author":"A Melber","year":"2018","journal-title":"Cell research"},{"issue":"11","key":"pcbi.1010439.ref148","doi-asserted-by":"crossref","first-page":"539","DOI":"10.5483\/BMBRep.2017.50.11.157","article-title":"Two distinct nodes of translational inhibition in the Integrated Stress Response","volume":"50","author":"HD Ryoo","year":"2017","journal-title":"BMB reports"},{"issue":"6489","key":"pcbi.1010439.ref149","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5314","article-title":"The integrated stress response: From mechanism to disease","volume":"368","author":"M Costa-Mattioli","year":"2020","journal-title":"Science"},{"issue":"3","key":"pcbi.1010439.ref150","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/nar\/gkp1034","article-title":"Differential regulation of CHOP translation by phosphorylated eIF4E under stress conditions","volume":"38","author":"YJ Chen","year":"2009","journal-title":"Nucleic acids research"},{"issue":"8","key":"pcbi.1010439.ref151","doi-asserted-by":"crossref","first-page":"e1003529","DOI":"10.1371\/journal.pgen.1003529","article-title":"Gene expression regulation by upstream open reading frames and human disease","volume":"9","author":"C Barbosa","year":"2013","journal-title":"PLoS genetics"},{"issue":"3","key":"pcbi.1010439.ref152","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/neu.2011.1940","article-title":"Deletion of the pro-apoptotic endoplasmic reticulum stress response effector CHOP does not result in improved locomotor function after severe contusive spinal cord injury","volume":"29","author":"SS Ohri","year":"2012","journal-title":"Journal of Neurotrauma"},{"issue":"12","key":"pcbi.1010439.ref153","doi-asserted-by":"crossref","first-page":"10811","DOI":"10.1007\/s11033-012-1975-3","article-title":"ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia","volume":"39","author":"LR Pike","year":"2012","journal-title":"Molecular biology reports"},{"issue":"12","key":"pcbi.1010439.ref154","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1016\/j.bbamcr.2013.07.024","article-title":"When ER stress reaches a dead end","volume":"1833","author":"H Urra","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"issue":"5","key":"pcbi.1010439.ref155","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3892\/ol.2014.1922","article-title":"TRAIL combinations: The new\u2019trail\u2019 for cancer therapy","volume":"7","author":"A Refaat","year":"2014","journal-title":"Oncology letters"},{"issue":"3","key":"pcbi.1010439.ref156","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/cancers10030068","article-title":"Tannic acid induces endoplasmic reticulum stress-mediated apoptosis in prostate cancer","volume":"10","author":"PK Nagesh","year":"2018","journal-title":"Cancers"},{"key":"pcbi.1010439.ref157","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.3389\/fimmu.2018.03083","article-title":"The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection","volume":"9","author":"H Hu","year":"2019","journal-title":"Frontiers in immunology"},{"issue":"3","key":"pcbi.1010439.ref158","doi-asserted-by":"crossref","first-page":"e01599","DOI":"10.1128\/AAC.01599-17","article-title":"Mitochondrial alterations (inhibition of mitochondrial protein expression, oxidative metabolism, and ultrastructure) induced by linezolid and tedizolid at clinically relevant concentrations in cultured human HL-60 promyelocytes and THP-1 monocytes","volume":"62","author":"TV Milosevic","year":"2018","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"pcbi.1010439.ref159","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.nbd.2009.02.005","article-title":"Inhibition of mitochondrial function induces an integrated stress response in oligodendroglia","volume":"34","author":"JM Silva","year":"2009","journal-title":"Neurobiology of disease"},{"issue":"1","key":"pcbi.1010439.ref160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biocel.2011.10.012","article-title":"Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics","volume":"44","author":"R Bravo","year":"2012","journal-title":"The international journal of biochemistry & cell biology"},{"issue":"1","key":"pcbi.1010439.ref161","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.211","article-title":"Role of endoplasmic reticulum stress in drug-induced toxicity","volume":"4","author":"F Foufelle","year":"2016","journal-title":"Pharmacology research & perspectives"},{"issue":"2","key":"pcbi.1010439.ref162","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"AJ Souers","year":"2013","journal-title":"Nature medicine"},{"issue":"2","key":"pcbi.1010439.ref163","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1021\/bp034226s","article-title":"A dynamic mathematical model to clarify signaling circuitry underlying programmed cell death control in Arabidopsis disease resistance","volume":"20","author":"V Agrawal","year":"2004","journal-title":"Biotechnology progress"},{"issue":"1","key":"pcbi.1010439.ref164","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3324\/haematol.11575","article-title":"Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model","volume":"93","author":"P Montesinos","year":"2008","journal-title":"Haematologica"},{"issue":"5","key":"pcbi.1010439.ref165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members","volume":"9","author":"M Certo","year":"2006","journal-title":"Cancer cell"},{"issue":"1","key":"pcbi.1010439.ref166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02393-7","article-title":"Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade","volume":"4","author":"M Przedborski","year":"2021","journal-title":"Communications Biology"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T17:27:34Z","timestamp":1663090054000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010439"}},"subtitle":[],"editor":[{"given":"Stacey","family":"Finley","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":166,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1010439","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]}}}